Swiss stocks - Factors to watch on May 31

U Blox Holding AG

31/05/2022 05:37

ZURICH/BERLIN, May 31 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Tuesday:
    
    FIRMENICH/DSM
    Dutch specialty chemicals maker DSM  DSMN.AS  said it would
merge with its Swiss peer Firmenich in an all-share deal, to
become a leading supplier of food ingredients and beauty and
well-being products.
    For more, click on  urn:newsml:reuters.com:*:nL1N2XN06W
    
    CREDIT SUISSE  CSGN.S 
    Credit Suisse is in the early stages of weighing options to
bolster its capital after a string of losses have eroded its
financial buffers, two people with knowledge of the matter told
Reuters.  urn:newsml:reuters.com:*:nL1N2XM147
      
    NESTLE  NESN.S 
    Nestle does not expect "significant infant formula
shortages" in other markets the Swiss food maker serves outside
the United States, Chief Executive Mark Schneider said in an
interview Monday.
    
    COMPANY STATEMENTS
    * DKSH Business Unit Healthcare  DKSH.S  said it signed an
agreement to acquire Acutest Systems, a Malaysian in-vitro
diagnostic provider.  DKSH.S  
    * Helvetia Insurance  HELN.S  said operating profit in 2021
came to CHF 81.1 million and was therefore 29% higher than in
the previous year.  HELN.S 
    * Kuros Biosciences  KURN.S  announced preliminary results
from the first of its five planned randomized controlled trials
for its MagnetOs family, comparing MagnetOs Granules to the gold
standard of autograft bone.  KURN.S 
    * Relief Therapeutics  RLFB.S  said it would continue the
development of aviptadil in both inhaled and intravenous
formulations for other indications after a trial evaluating it
for the treatment of COVID-19 was discontinued.  RLFB.S 
    * Roche  ROG.S  said the FDA approved its Evrysdi for use in
babies under two months with spinal muscular atrophy.  ROG.S 
    * Swiss Life  SLHN.S  said it generated a positive operating
result of CHF 124 million with its group insurance in the past
financial year.  SLHN.S 
    * u-blox  UBXN.S  raised its guidance, now expecting its
full year 2022 revenue to increase in the range of 27% to 39%
and further improvements in EBITDA and EBIT margins.  UBXN.S 
    * Zur Rose Group  ROSEG.S  said Betül Susamis Unaran, Chief
Strategy and Digital Officer as well as member of the Executive
Board, has decided to pursue new career paths and leave the
group.  ROSEG.S 
        
    ANALYSTS' VIEWS
    MEDMIX LTD  MEDX.S : CREDIT SUISSE CUTS TO NEUTRAL FROM
OUTPERFORM; CUTS TARGET PRICE TO CHF 30 FROM CHF 46
    LONZA GROUP AG  LONN.S : JEFFERIES CUTS TARGET PRICE TO CHF
700 FROM CHF 770
    
    ECONOMY    
    Swiss Q1 GDP due at 0800 GMT. Seen +0.3% q/q, +4.3% y/y.

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))